Objective The Consortium on the Genetics of Schizophrenia has undertaken a large
multisite study to characterize 12 neurophysiological and neurocognitive endophenotypic …

Prohibitins (PHBs) are conserved proteins in eukaryotic cells, which are mainly located in
the inner mitochondrial membrane (IMM), cell nucleus, and cell membrane. PHBs play …

Schizophrenia (SZ) is a common disorder that runs in families. It has a relatively high
heritability, ie inherited factors account for the major proportion of its etiology. The high …

Prohibitin has previously been implicated in the synaptic pathology of schizophrenia. The
recently discovered abundant expression of prohibitin in human prefrontal oligodendrocytes …

The clinical expression of schizophrenia is generally reported to be expressed by three to
five different factors (ie positive, negative, disorganization, excitability, anxiety–depression …

Schizophrenia (SCZ) is a debilitating disorder with a prevalence of approximately 1%
worldwide. SCZ is known to have a high degree of genetic and clinical heterogeneity and is …

Pure distal monosomy of the long arm of chromosome 10 is a rare cytogenetic abnormality.
The location and size of the deletions described in this region are variable. Nevertheless …

Obsessive–compulsive symptoms (OCSs) or comorbid obsessive–compulsive disorder
(OCD) commonly occurs in the course of schizophrenia. Considering the heritability of OCD …

Research into the genetic basis of schizophrenia is advancing rapidly. This review gives a
broad overview of results from successive phases of studies in this field, linking these with …

Symptom dimensions of schizophrenia are likely to be the intermediate phenotypes under
the control of disease-susceptibility genes, or separate traits related to disease-modifier …